Xcout Intel
Neogene Therapeutics, Inc.
Neogene Therapeutics, Inc. is a global clinical-stage biotechnology company focused on the discovery and development of engineered T cell receptor therapies targeting cancer. The company has maintained dual headquarters with a U.S. base in Santa Monica, California, and an EU base in Amsterdam, before being acquired by AstraZeneca.
Subscribe to see Neogene Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Neogene Therapeutics, Inc. at a glance
Neogene Therapeutics, Inc. is an oncology company headquartered in United States. It has raised at least $125M across the 2 funding rounds on record. Its most recent funding round, Series A, raised $110M in September 2020.
Neogene Therapeutics, Inc. funding rounds
At least $125M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $110M | 11 named | |
| Seed | $15M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Neogene Therapeutics, Inc. competitors
A few of Neogene Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
Amolyt Pharma is a clinical-stage biotechnology company specializing in the development of therapeutic peptides for rare endocrine diseases. Acquired by AstraZeneca, the company focuses on advancing innovative treatments through clinical trials.
Ambrx Biopharma was a clinical-stage biopharmaceutical company that developed antibody-drug conjugates and other targeted therapeutics using its proprietary expanded genetic code technology for site-specific protein modification. Its programs were aimed at treating cancers and served patients through partnerships and clinical development; Johnson & Johnson acquired Ambrx in 2024.
Headquartered in South San Francisco, California, Chimera Bioengineering is a privately held biotechnology company focused on developing advanced cellular engineering technologies for cancer therapies.
Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company headquartered in South San Francisco, California. It specializes in developing novel T-cell engaging therapies for the treatment of cancer.
Get Neogene Therapeutics, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Neogene Therapeutics, Inc. in Xcout Intel
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access